dsm-firmenich has introduced a new microalgal omega-3 oil designed as a fish oil replacement for pet food formulations, marking another step in the pet nutrition industry’s shift toward more sustainable and traceable ingredient sources.

Presented at Petfood Forum 2026 in Kansas City, the new ingredient is positioned for use in pet food applications where EPA and DHA omega-3 fatty acids are required. According to the company, the solution provides the same natural 3:2 EPA:DHA ratio found in high-quality fish oil, allowing manufacturers to maintain the nutritional profile expected from marine omega-3 sources while reducing dependence on conventional fish-derived inputs.

From the perspective of the pet nutrition market, the launch comes at a time when functional ingredients are becoming increasingly important in product differentiation. Omega-3 fatty acids are widely associated with support for skin and coat condition, joint health, heart health, brain function and overall wellbeing in companion animals. As pet owners become more attentive to the long-term health value of diets, ingredients that combine nutritional functionality with sustainability are gaining strategic importance for pet food brands.

The use of microalgae also addresses a broader supply-chain question for the industry. Fish oil has long been an important source of EPA and DHA, but pet food manufacturers are increasingly evaluating alternatives that can offer consistency, scalability and reduced pressure on marine ecosystems. By using algae as the original biological source of omega-3s, this type of ingredient can help companies maintain key nutritional benefits while supporting sustainability commitments.

For pet food producers, the commercial relevance lies not only in replacing one ingredient with another, but in protecting formulation flexibility. A fish oil alternative that can deliver comparable EPA and DHA characteristics may help brands manage sourcing risks, respond to consumer expectations and develop premium products with clearer sustainability positioning.

The launch also underlines the growing connection between human nutrition technologies and pet nutrition innovation. Ingredients that were once discussed mainly in the context of human health are increasingly being adapted for companion animal diets, particularly in premium and science-led categories. This reflects the continuing humanization of pet care, where owners expect higher-quality, purpose-driven nutrition for dogs and cats.

For dsm-firmenich, the move strengthens its role in the pet nutrition ingredients market, where functionality, sustainability and formulation reliability are becoming central to competition. For the broader pet food sector, algal omega-3 solutions may represent a practical route to balancing animal health benefits with more resilient sourcing strategies.